BioCentury
ARTICLE | Clinical News

United Therapeutics completes Phase III enrollment

February 26, 2001 8:00 AM UTC

UTHR completed enrollment of its 116-patient, double-blind, placebo-controlled Phase III study of beraprost oral synthetic prostacyclin analog to treat pulmonary hypertension. The U.S. study is assess...